Predicting Molecular Geometry
Prediction Intervals
Tumor Progression
End Point Prediction: Gran Plot
Sensitivity, Specificity, and Predicted Value
mTOR Signaling and Cancer Progression
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 3, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Peyman Ghorbani1,2, Tyler Kt Smith1,2, Morgan D Fullerton1,2,3
1Centre for Infection, Immunity and Inflammation, Ottawa, Ontario, Canada.
Metabolites of the mevalonate pathway, specifically geranylgeranyl diphosphate synthase (GGPPS), may regulate the progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH). GGPPS dysregulation impairs lipid oxidation despite increased AMPK activation in NASH.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: